Mindray Medical (MR) Posts Q3 EPS of $0.38, Tops by 11c
More News related to MR
- Goldman Sachs Upgraded Mindray Medical (MR) to Conviction Buy
- Mindray to Hold Annual General Meeting in Hong Kong on December 15, 2009
- Mindray Medical to Exhibit at RSNA 2009 in Chicago, from November 29th to December 4th, 2009
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Mindray Medical (MR) Posts Q3 EPS of $0.38, Tops by 11c
More News related to Earnings
- Highlights From SJM's Q2 Conference Call: Acquisition of Folger's Really Paying Off; Comfortable Raising FY Outlook
- Highlights From INTU's Q1 Conference Call: Issues Mixed Guidance for Q2, In-line for FY10
- Highlights From The GAP's (GPS) Q3 Conference Call: Total Comp-Store Sales Were Flat Vs. Down 12% Last Year
- Highlights From DELL's Q3 Conference Call: Revenues Adversely Affected By Timing of Windows 7 Launch
- D. R. Horton (DHI) Home Orders Rise, But Losses Continue
Mindray Medical International Limited (NYSE: MR) reports Q3 EPS of $0.38, 11 cents better than the analyst estimate of $0.27. Revenue for the quarter was $151.1 million, which compares to the estimate of $154.98 million.
Related Categories
EarningsStocks Mentioned
-0.15Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
